NCT03366376Unknown2 期
A Phase II Multi-institutional Study of Hippocampus-sparing Whole Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Non-small Cell Lung Cancer
适应症
干预措施
试验速览
- 阶段
- 2 期
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Intracranial progression free survival
研究概览
简要总结
This study evaluates hippocampus-sparing whole-brain radiotherapy with simultaneous integrated boost for patients with multiple brain metastases from non-small cell lung cancer. The primary endpoint is intracranial progression free survival, and secondary endpoints are verbal neurocognitive function, overall survival, adverse events according to CTCAE v4.03, and quality of life.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 55 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pathologically proven diagnosis of primary non-small cell lung cancer
- •3 or more measurable brain metastasis ≥3 mm outside a 5-mm margin around either hippocampus on gadolinium contrast enhanced MRI within 14 days prior to registration
- •Age ≥55 years
- •Informed consent prior to study entry
排除标准
- •Patients with leptomeningeal metastases
- •≥3 organ sites of extracranial metastases (including lung-to-lung metastases) within 3 months
- •Contraindication to MRI such as implanted metal devices or foreign bodies
- •Prior radiation therapy (including SRS) to the brain
研究组 & 干预措施
Experimental
Experimental
WBRT with hippocampus-sparing and SIB
干预措施: WBRT with hippocampus-sparing and SIB (Radiation)
结局指标
主要结局
Intracranial progression free survival
时间窗: until 12 months
Time from the date of start of radiotherapy to the date of death or intracranial progression
次要结局
- Quality of life(3,6,12 months)
- Adverse events(3,6,12 months)
- Verbal neurocognitive function (Seoul Verbal Learning Test-Elderly, SVLT-E)(3,6,12 months)
- Overall survival(until 12 months)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung CancerMetastatic Malignant Neoplasm in the LeptomeningesMetastatic Breast CarcinomaStage IV Lung Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaAnatomic Stage IV Breast Cancer AJCC v8NCT06518057University of Washington22
终止
3 期
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryAnatomic Stage IV Breast Cancer AJCC v8Metastatic Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Renal Cell Cancer AJCC v8Metastatic Malignant Breast NeoplasmMetastatic MelanomaMetastatic Renal Cell CarcinomaRecurrent Brain NeoplasmStage IV Lung Cancer AJCC v8Metastatic Malignant Digestive System NeoplasmNCT04588246NRG Oncology19
已完成
2 期
Hippocampal Sparing Whole Brain Radiotherapy vs Conventional Whole Brain Radiotherapy in Patients With Brain MetastasesBrain MetastasesNCT02147028University College, London23
已完成
2 期
Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRTBrain MetastasesNCT04452084National Cancer Centre, Singapore42
已完成
2 期
Phase 2 study of whole brain radiotherapy with hippocampal-avoidance and simultaneous integrated boost to brain metastases using intensity modulated radiotherapyBrain metastasisJPRN-UMIN000010226Division of Radiation Oncology and division of Neurooncology, National Cancer Center Hospital, Tokyo, Japan54